/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

bioAffinity Technologies Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.57 0.0979(9.79%) BIAF at 04 Dec 2025 04:26 PM Diagnostics & Research
Lowest Today 1.505
Highest Today 1.64
Today’s Open 1.505
Prev. Close 1.43
52 Week High 46.53
52 Week Low 1.25
Day’s Range: Low 1.505 High 1.64
52-Week Range: Low 1.25 High 46.53
1 day return -
1 Week return +4.66
1 month return -23.78
3 month return +563.84
6 month return +428.26
1 year return +45.37
3 year return -48.52
5 year return -
10 year return -

Institutional Holdings

Geode Capital Management, LLC 0.42

Fidelity Extended Market Index 0.34

Vanguard Institutional Extnd Mkt Idx Tr 0.20

Hanson Mcclain Inc 0.18

Sheaff Brock Investment Advisors, LLC 0.18

Vanguard Group Inc 0.14

CapTrust Financial Advisors 0.09

IFP Advisors, LLC 0.08

Fidelity Series Total Market Index 0.07

Fidelity Nasdaq Composite Index 0.06

State Street Corp 0.06

XTX Topco Ltd 0.05

StoneX Group Inc 0.05

Fidelity Total Market Index 0.05

Northern Trust Corp 0.05

Creative Planning Inc 0.04

Spartan Total Market Index Pool G 0.04

SPROTT INC. 0.03

NT Ext Equity Mkt Idx Fd - NL 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

Northern Trust Extended Eq Market Idx 0.01

NT Ext Equity Mkt Idx Fd - L 0.01

Tower Research Capital LLC 0.01

Citigroup Inc 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

NT Ext Eq Mkt Indx Fd DC Lend T3 0.00

Spartan Extended Market Index Pool F 0.00

Bank of America Corp 0.00

Morgan Stanley - Brokerage Accounts 0.00

UBS Group AG 0.00

Barclays PLC 0.00

Citadel Advisors Llc 0.00

Warberg Asset Management LLC 0.00

Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 6.43 M

PB Ratio 0.7024

PE Ratio 0.0

Enterprise Value -0.74 M

Total Assets 6.51 M

Volume 244789

Company Financials

Annual Revenue FY23:321489 0.3M, FY22:4803 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY23:245289 0.2M, FY22:4336 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY23:-7238430 -7.2M, FY22:-8154113 -8.2M, FY21:-6326413 -6.3M, FY20:-7268737 -7.3M

Quarterly Revenue Q3/2025:1446066 1.4M, Q2/2025:1269483 1.3M, Q1/2025:1853597 1.9M, Q3/2024:2350386 2.4M, Q2/2024:2397652 2.4M

Quarterly Profit Q3/2025:390495 0.4M, Q2/2025:252881 0.3M, Q1/2025:485737 0.5M, Q3/2024:910228 0.9M, Q2/2024:989942 1.0M

Quarterly Net worth Q3/2025:-5051084 -5.1M, Q2/2025:-4060787 -4.1M, Q1/2025:-2660417 -2.7M, Q3/2024:-2000840 -2.0M, Q2/2024:-2110279 -2.1M

Fund house & investment objective

Company Information bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

Organisation Diagnostics & Research

Employees 57

Industry Diagnostics & Research

CEO Ms. Maria Zannes J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow